SNTI
Senti Biosciences Holdings, Inc.
A biotech company that builds cells engineered with "gene circuits" — biological software programmed in so the cells can sense, compute, and respond much like a computer. Its therapies target hard-to-treat cancers, and the engineered cells are designed to attack tumors while sparing healthy tissue. Founded in 2016 by synthetic-biology pioneers, the name "Senti" comes from the cells' ability to "sense" their environment.
CUSIP: 81726A1001 holder
Recent Activity
2024Q3
1 sell
-1.59M shares
ARK InvestEXIT
-1.59M shares
2024Q2
1 sell
-45.1K shares(-2.8%)
ARK InvestTRIM
-45.1K shares(-2.8%)
2024Q1
1 sell
-338.9K shares(-17.2%)
ARK InvestTRIM
-338.9K shares(-17.2%)
Loading more activity...